LLY - Eli Lilly and Co
501
$906.70
-$10.80 (-1.177%)
$911.48
$4.78 (0.527%)
Score4.55/5
Ownership Breakdown
Type | % Ownership | Market Value |
|---|---|---|
Insider | 0.18% | $1.51B |
Institutional | 84.52% | $724.08B |
Common & Other | 15.30% | $131.07B |
Insider Transactions
Ownership Details
Last Action | Total Value | Owner/Title | % Owned | % Change In Shares | Change In Shares | Share Count |
|---|
Sell | $83.32B | Lilly Endowment, Inc. | 9.73% | -0.32% | -293,538as of 2026-01-07 | 91.90M |
Buy | $73.97B | The Vanguard Group, Inc. | 8.64% | 1.24% | +997,738as of 2025-12-31 | 81.59M |
Sell | $46.35B | Pnc Investments Llc | 5.41% | -0.05% | -23,071as of 2025-12-31 | 51.12M |
Sell | $37.94B | Blackrock Institutional Trust Company, N.a. | 4.43% | -0.14% | -59,161as of 2025-12-31 | 41.84M |
Buy | $32.06B | State Street Investment Management Us | 3.74% | 1.83% | +635,358as of 2025-12-31 | 35.36M |
Sell | $22.27B | Capital Research Global Investors | 2.60% | -2.08% | -521,525as of 2025-12-31 | 24.57M |
Buy | $21.83B | Fidelity Management & Research Company Llc | 2.55% | 6.13% | +1,391,550as of 2025-12-31 | 24.08M |
Sell | $17.96B | Geode Capital Management, L.l.c. | 2.10% | -0.04% | -7,822as of 2025-12-31 | 19.81M |
Buy | $13.63B | Capital World Investors | 1.59% | 0.41% | +61,851as of 2025-12-31 | 15.03M |
Buy | $12.46B | T. Rowe Price Associates, Inc. | 1.45% | 11.76% | +1,445,317as of 2025-12-31 | 13.74M |